Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: Typical features of Critical Illness policies, and discussion of pricing, reserving, claims experience and regulations.

Description: Offering supplemental benefits likes accident, hospital indemnity and critical illness to traditional worksite employees has become routine, but how do you handle gig workers? Traditionally these workers would be considered uninsurable, but can you afford to ignore them? The panel will discuss the unique factors of the gig economies and key thoughts for providing insurance in this space.

Description: Critical Illness Insurance is one of the fastest growing insurance products available today. Carriers continue to introduce innovative approaches in second, third, and fourth generation products while refining their pricing, underwriting, and claims adjudication processes. This session will look back at historical trends using Gen Re's longstanding, comprehensive Critical Illness Market Survey, and look forward to potential market changes to occur in the next 18 months.

Description: Discussion of the RGA global survey of life insurers

Description: How Ready Are You for the Critical Illness Challenge? by Johan Lotter from Product Development News, August 2000, Issue No. 50.

Description: Critical Illness Insurance properties, underwriting issues, finding incidence rates, regulation issues, Rate Calibration Formula. Issue No. 39

Description: Article Description * A review of Critical Illness products in the market and product design and pricing considerations.

Description: Subtitle: My real-life connection to (almost) every supplemental product Data is king, but maybe it should be dethroned once in a while so we can better understand the "why" behind the data.